title: Plasma concentration profile of orally administered pimobendan and plasma brain natriuretic peptide level in patients with severe heart failure.
authors.forename: Michi
authors.initials: M
authors.lastname: Wakaumi
authors.forename: Tsuyoshi
authors.initials: T
authors.lastname: Shiga
authors.forename: Miyoko
authors.initials: M
authors.lastname: Naganuma
authors.forename: Naoki
authors.initials: N
authors.lastname: Matsuda
authors.forename: Shinji
authors.initials: S
authors.lastname: Tatami
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Kasanuki
mesh_terms: D000284:Administration, Oral; D002311:Cardiomyopathy, Dilated / Q000150:complications; D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D011724:Pyridazines / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use
chemical_list: D002316:Cardiotonic Agents; D011724:Pyridazines; D020097:Natriuretic Peptide, Brain; C041648:pimobendan; C047936:UD CG 212 Cl